Share
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
CANCER RESEARCH
Leroy, B; Ballinger, ML; Baran-Marszak, F; Bond, GL; Braithwaite, A; Concin, N; Donehower, LA; El-Deiry, WS; Fenaux, P; Gaidano, G; Langerod, A; Hellstrom-Lindberg, E; Iggo, R; Lehmann-Che, J; Mai, PL; Malkin, D; Moll, UM; Myers, JN; Nichols, KE; Pospisilova, S; Ashton-Prolla, P; Rossi, D; Savage, SA; Strong, LC; Tonin, PN; Zeillinger, R; Zenz, T; Fraumeni, JF; Taschner, PEM; Hainaut, P; Soussi, T, 2017: Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. CANCER RESEARCH 77(6), p. 1250 - 1260, doi: 10.1158/0008-5472.CAN-16-2179
Research Groups:
CEITEC authors: